JANE STREET GROUP, LLC - SANA BIOTECHNOLOGY INC ownership

SANA BIOTECHNOLOGY INC's ticker is SANA and the CUSIP is 799566104. A total of 118 filers reported holding SANA BIOTECHNOLOGY INC in Q1 2023. The put-call ratio across all filers is 3.06 and the average weighting 0.1%.

Quarter-by-quarter ownership
JANE STREET GROUP, LLC ownership history of SANA BIOTECHNOLOGY INC
ValueSharesWeighting
Q3 2023$273,284
-50.8%
70,616
-24.2%
0.00%
Q2 2023$554,894
+121.1%
93,103
+21.3%
0.00%
Q1 2023$250,946
+6.3%
76,742
+95.0%
0.00%
Q3 2022$236,000
-19.7%
39,347
-14.1%
0.00%
Q2 2022$294,000
+47.0%
45,801
+255.0%
0.00%
Q4 2021$200,000
-32.7%
12,900
-2.3%
0.00%
Q3 2021$297,00013,2000.00%
Other shareholders
SANA BIOTECHNOLOGY INC shareholders Q1 2023
NameSharesValueWeighting ↓
Flagship Pioneering Inc. 34,239,018$220,158,0008.29%
Crestline Management, LP 3,365,624$21,641,0002.82%
Omega Fund Management, LLC 843,750$5,425,0001.73%
Alphabet Inc. 2,812,500$18,084,0000.98%
HARVARD MANAGEMENT CO INC 468,749$3,014,0000.35%
PUBLIC SECTOR PENSION INVESTMENT BOARD 6,400,000$41,152,0000.35%
PFM Health Sciences, LP 952,733$6,126,0000.23%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 156,254$1,005,0000.20%
Viewpoint Capital Management LLC 23,545$151,0000.14%
Artal Group S.A. 400,000$2,572,0000.14%
View complete list of SANA BIOTECHNOLOGY INC shareholders